Validation of the association of RECIST changes with survival in men with metastatic castration resistant prostate cancer treated on SWOG study S0421

BACKGROUND: Phase II trials evaluating new agents for metastatic castration-resistant prostate cancer (mCRPC) have relied on bone scan and prostate specific antigen (PSA) changes to assess activity. Given the increasing detection of measurable disease, RECIST changes warrant consideration to evaluat...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Genitourin Cancer
Main Authors: Sonpavde, Guru, Pond, Gregory R., Plets, Melissa, Tangen, Catherine M., Hussain, Maha H.A., Lara, Primo N., Goldkorn, Amir, Garzotto, Mark G., Mack, Philip C., Higano, Celestia S., Vogelzang, Nicholas J., Thompson, Ian M., Twardowski, Przemyslaw W., Van Veldhuizen, Peter J., Agarwal, Neeraj, Carducci, Michael A., Monk, J. Paul, Quinn, David I.
Format: Artigo
Sprog:Inglês
Udgivet: 2017
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5734863/
https://ncbi.nlm.nih.gov/pubmed/28579151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2017.05.014
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker